News on Ranexa from BioPortfolio.com http://www.BioPortfolio.com Consolidated Ranexa news from BioPortfolio.com Wed, 10 Feb 2010 16:38:23 GMT en Gilead Fourth Quarter Profit Rises 43% on Atripla Saleshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3980164&HITNO=0&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ranexa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3980164&THISHREF=http://c.moreover.com/click/here.pl%3fz2506246289%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3980164&HITNO=0&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ranexa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3980164&THISHREF=http://c.moreover.com/click/here.pl%3fz2506246289%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceuticalProcessing: Gilead 4Q Profit Rises 43 Percent on Atripla Saleshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3969044&HITNO=1&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ranexa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3969044&THISHREF=http://c.moreover.com/click/here.pl%3fz2500658565%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3969044&HITNO=1&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ranexa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3969044&THISHREF=http://c.moreover.com/click/here.pl%3fz2500658565%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Gilead Sciences' 3-in-1 HIV treatment became its top drug in 4Q as Atripla sales rose 50 pcthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3966527&HITNO=2&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ranexa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3966527&THISHREF=http://c.moreover.com/click/here.pl%3fz2499066746%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3966527&HITNO=2&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ranexa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3966527&THISHREF=http://c.moreover.com/click/here.pl%3fz2499066746%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDCExaminer.com: Gilead 4Q profit rises 43 percent on Atripla saleshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3966485&HITNO=3&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ranexa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3966485&THISHREF=http://c.moreover.com/click/here.pl%3fz2499045413%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3966485&HITNO=3&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ranexa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3966485&THISHREF=http://c.moreover.com/click/here.pl%3fz2499045413%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comForbes.com: Gilead 4Q profit rises 43 percent on Atripla saleshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3966406&HITNO=4&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ranexa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3966406&THISHREF=http://c.moreover.com/click/here.pl%3fz2499016494%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3966406&HITNO=4&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ranexa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3966406&THISHREF=http://c.moreover.com/click/here.pl%3fz2499016494%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Ranexa (ranolazine extended-release tablets)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3961463&HITNO=5&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ranexa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3961463&THISHREF=http://c.moreover.com/click/here.pl%3fz2496784086%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3961463&HITNO=5&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ranexa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3961463&THISHREF=http://c.moreover.com/click/here.pl%3fz2496784086%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedscape: TargetCast tcm Acquires Triumph360http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3898180&HITNO=6&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ranexa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3898180&THISHREF=http://c.moreover.com/click/here.pl%3fz2462627046%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3898180&HITNO=6&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ranexa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3898180&THISHREF=http://c.moreover.com/click/here.pl%3fz2462627046%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comUlitzer: